In tumor cells, it has been demonstrated that the mTOR pathway is responsible for stimulating tumorigenesis, inducing the expression of inhibitory molecules, such as programmed cell death ligand-1 (PDL-1), and suppressing anticancer immune responses [65]. The gene discussed is CD274; the disease is neoplasm.